Vp Development
CurrentClear Creek Bio is a start up pharmaceutical company developing novel therapeutics for the treatment of cancer.
Please complete the CAPTCHA to continue
@epix.net
✓
3 phones found area 610 and 484
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
David Hesson is listed as VP Development at Clear Creek Bio, Inc at Clear Creek Bio, Inc., based in Malvern, Pennsylvania, United States. AeroLeads shows a work email signal at epix.net, phone signal with area code 610, 484, and a matched LinkedIn profile for David Hesson.
David Hesson previously worked as VP Development at Clear Creek Bio, Inc. and Business Advisor Mentor and Member Advisor Steering Committee at University City Science Center Qed. David Hesson holds Ph.D., Organic Chemistry from Massachusetts Institute Of Technology.
This section adds company-level context without repeating David Hesson's masked contact details.
AeroLeads found 1 current-domain work email signal for David Hesson. Compare company email patterns before reaching out.
I am an accomplished scientific professional with thirty years of experience in the discovery and development of pharmaceuticals. My major strengths are building organizations for pharmaceutical drug research and development, regulatory filing in US and EU, planning and strategy. My core skills are in pharmaceutical development, R&D management and planning, project management, neuroscience, cancer research, pharmaceutical patents, and academic and government research collaborationsSpecialties: Small molecule development, proteins, peptides.Oncology, neuroscience, fibrosis.Experience in filing IND, IMPD, NDA, BLA.
Listed skills include Biotechnology, Drug Development, Pharmaceutical Industry, Clinical Development, and 22 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Clear Creek Bio is a start up pharmaceutical company developing novel therapeutics for the treatment of cancer.
Work with academic groups in the Pennsylvania and Delaware to translate and develop research strategies for drug and diagnostic products.
I provide research planning and CMC drug development advise to early stage and start-up biotech and pharmaceutical companies.
Working in the laboratory of Dr. Mark Greene to develop strategies of translation of current research programs into development.
LytPhage is a start up biotech company developing novel bacterial virus, bacteriophage, technology to treat life threatening antibiotic resistant infections.
I provided chemistry development support.
Promedior is a start up (March 2006) therapeutic biotech company developing drugs for the treatment of fibrotic diseases. I was responsible for planning, building, and managing the pharmaceutical development portion of Promedior. I also managed the IP portfolio.• Hired a 10 person development team including safety/toxicology and biopharmaceutical manufacturing in 9 months.• Developed from DNA via CMO’s the cloning, expression and cGMP manufacture of 125 kDa protein in 15 months.• Developed preclinical pharmacology programs with 8 leading academic fibrosis research groups.• Completed the execution in 2 years of a preclinical pharmacology, toxicology and CMC data necessary to file the IND submission of PRM-151 a recombinant human protein.
Martinsried, De
I planned and coordinated all parts of development-phase projects from preclinical to commercial launch. I helped business development evaluate and rank potential in-licensing candidates. I was a member of the due diligence team providing background for prospective partners. • Planned and executed the satraplatin worldwide Phase III satraplatin pivotal trial and US & EU regulator filings.• Organized satraplatin rolling NDA submission and European EMEA filings.• Planned two small molecule CDK antagonists and one in-licensed pre-clinical to Phase I US projects.• Planned and executed the antibody 1D09C3 preclinical to Phase I European project.• Supported partnering negotiations with Pharmion 2005 and other ongoing partnership opportunities.
Lead a research team of 36 persons.
Quick answers generated from the profile data available on this page.
David Hesson works for Clear Creek Bio, Inc..
David Hesson is listed as VP Development at Clear Creek Bio, Inc at Clear Creek Bio, Inc..
AeroLeads has found 1 work email signal at @epix.net for David Hesson at Clear Creek Bio, Inc..
AeroLeads has found 3 phone signal(s) with area code 610, 484 for David Hesson at Clear Creek Bio, Inc..
David Hesson is based in Malvern, Pennsylvania, United States while working with Clear Creek Bio, Inc..
David Hesson has worked for Clear Creek Bio, Inc., University City Science Center Qed, Dp Hesson Consulting, Univeristy Of Pennsylvania Medical School, and Lytphage, Inc..
You can use AeroLeads to view verified contact signals for David Hesson at Clear Creek Bio, Inc., including work email, phone, and LinkedIn data when available.
David Hesson holds Ph.D., Organic Chemistry from Massachusetts Institute Of Technology.
David Hesson is listed with skills including Biotechnology, Drug Development, Pharmaceutical Industry, Clinical Development, Biopharmaceuticals, Clinical Trials, Oncology, and Drug Discovery.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts